Cash aplenty at REIT, pharma firm; insurer continues to retrench
A.J. Kazimi talks about Cumberland Pharmaceuticals' low-risk strategy and the need to set a precedent [From our print edition featured in Monday's City Paper]
Summit-area docs on the move, Deloitte secures power, CPIX spices up West End digs, and more...
Retailer pops on estimate beat, newly public drug developer ramps up marketing program
Stock climbs by more than 10 percent in first day on NYSE
IPO comes out at top of expected range
Specialty pharmaceuticals company launches its initial public offering today -- CEO Kazimi comments
Earnings from Cumberland Pharmaceuticals, schools and unions talk about cooperating, and more...
Healthcare billing services provider looking to raise $460M